B cells in systemic sclerosis: from pathophysiology to treatment

Area of Science:

• Immunology
• Rheumatology
• Autoimmune Diseases

Background:

• Systemic sclerosis is a severe autoimmune condition with poorly understood origins.
• Vascular and immune system abnormalities precede the characteristic fibrosis.
• B cells, a component of adaptive immunity, are notably dysregulated in patients.

Purpose of the Study:

• To review B cell aberrations in systemic sclerosis models and patients.
• To summarize current data on therapeutic B cell targeting in systemic sclerosis.

Main Methods:

• Review of existing literature on B cell function in systemic sclerosis.
• Analysis of B cell subsets in peripheral blood and affected tissues.
• Examination of animal models and human patient data.

Main Results:

• B cells exhibit aberrant activation and impaired regulatory capacity in systemic sclerosis.
• B cell infiltration of skin and lungs suggests a role in pathogenesis.
• B cell depletion strategies demonstrate therapeutic potential.

Conclusions:

• Dysregulated B cell homeostasis is a key feature of systemic sclerosis.
• Targeting B cells represents a promising therapeutic avenue.
• Further research into B cell-targeted therapies is warranted.